The question of Marathon Oil (MRO) being undervalued by investors is being debated. In the recent times, MRO has been reiterated as a 'Buy' by Benchmark, however, its price target has been cut to $35.00 significantly. Analysts have given mixed responses with 18 detailed ratings, painting a complex picture of Marathon Oil's performance. In Q1 2024, MRO missed EPS and revenue expectations, but was productive due to oil price improvement.
A significant 1.36% movement in Marathon Oil stock keeps the investors intrigued about their next moves. The firm's position in New York Life Investment Management's portfolio valued at $2.02 million. Also, shares have been purchased by Victory Capital Management Inc, marking a healthy capital influx.
The stock showed a gain in the market dip but has also experienced a 17.8% fall since the last earnings report. The company's Executive VP and CFO, Dane Whitehead sold 73,233 shares of MRO, while the institutional shareholders own approximately 78% of the company.
The company’s consistent dividend payout of $0.11 proves its commitment to shareholders. Wall Street analysts forecast a 40% upside in Marathon Oil and recommend a 'Buy' at StockNews.com. Despite these positive reviews, MRO stock often underperforms in comparison to competitors. MRO's dividend trend and institutional ownership speak volumes about its market consistency.
Finally, analysts predict a strong 2024 for Marathon Oil with potentially 30% stock upswing, despite ongoing market fluctuations.
Marathon Oil Stocks MRO News Analytics from Fri, 13 Oct 2023 07:00:00 GMT to Tue, 07 May 2024 13:40:15 GMT - Rating 2 - Innovation -5 - Information 8 - Rumor -6
